Formula: C20H17NO6

MW: 367.36

CAS: 485-49-4

MDL:

TNP: TNP00145

(r-(r*,s*))-6-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-furo(3,4-e)-1,3-benzodioxol-8(6h)-one; [R-(R*,S*)]-6-(5,6,7,8-TETRAHYDRO-6-METHYL-1,3-DIOXOLO[4,5-G]ISOQUINOLIN-5-YL)FURO[3,4-E]-1,3-BENZODIOXOL-8(6H)-ONE; (+)-BICUCULINE; (+)-BIC

LogP: 1.13

LogS: -4.14

Acceptors: 6

Donors: 0

Rotation Bonds: 1

Chiral Centers: 2

N+O: 7

LIPINSKY: 4

IUPAC: (6R)-6-((5R)-6-methyl(5,6,7,8-tetrahydro-2H-1,3-dioxoleno[4,5-g]isoquinolin-5- yl))-6-hydro-2H-1,3-dioxoleno[4',5'-5,6]benzo[b]furan-7-one

Smiles: c12c(cc3c(c1)OCO3)[C@@H]([C@H]1(c3c(OC1=O)c1c(cc3)OCO1))(N(CC2)C)

Specification: Alkaloids; Intermediates & Fine Chemicals; Pharmaceuticals; GABA/Glycine receptor; GABA (+)-Bicuculline Chemical Properties:

mp 193-197 C storage temp. 0-6C Merck 13,1207 CAS DataBase Reference485-49-4(CAS DataBase Reference) EPA Substance Registry SystemFuro[3,4-e]-1,3- benzodioxol-8(6H)-one, 6-[(5S)-5,6,7,8-tetrahydro- 6-methyl-1,3-dioxolo[4,5- g]isoquinolin-5-yl]-, (6R)-(485-49-4) Safety Information Hazard Codes T,N,Xn Risk Statements 23/24/25-50-36/37/38-20/21/22 Safety Statements 36/37-45-61-36-26 RIDADR UN 1544 6.1/PG 2 WGK Germany 3 RTECS LV0909840 F 10-23 HazardClass 6.1(b) PackingGroup III (R-(R*,S*))-6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-furo(3,4-e)-1,3-benzodioxol-8(6H)-one English (+)-Bicuculline Usage And Synthesis Chemical Properties:

Pale Yellow Solid UsageAlkaloid naturally occurring in the d-form. Shows GABA antagonist activity. Biological ActivityClassical GABA A antagonist. (+)-Bicuculline

< Prev		Next >

Chemical Compounds - Natural Compounds